Dr. Emily Stein, Ph.D., began working on the solution for oral dysbiosis (a key driver of gum disease) in 2008 after she witnessed both her grandmother and 10 year old rescue dog suffer nearly fatal episodes caused by advanced dental disease. Unable to find any safe or effective dental products on the market, she focused on producing consumable oral microbiome-improving products that are 100% safe for human and animal consumption.

Her patented technology in TEEF's Protektin™ formulations leverage a molecular approach called Selective Microbial Metabolism Regulation Technology (SMMRT)®, which is focused on using nutrients to steer bacterial behaviors toward health-promoting vs. disease-causing. It's a natural approach to growing the good bacteria needed for great dental health and fresh breath.

Dr. Stein continues to work to redefine the landscape of oral and systemic health. Her leadership is driving the development of cutting-edge microbiome modulatory products, while unraveling the intricacies of biofilm-related oral and systemic diseases.

She has 18 patents, has delivered over 23 professional lectures on the global stage and has earned numerous awards and accolades, making her a respected authority in the realm of oral microbiome and soft tissue inflammation.

Dr. Stein earned a Ph.D. in Microbiology at UC Berkeley and completed her Post-Doctoral Fellowship at Stanford University School of Medicine, in the Department of Immunology & Rheumatology. The microbiome modulatory technology that she has developed holds promise in addressing an array of diseases that range from dental cavities and periodontal disease to cancer and diabetes.